RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA)

Clinical trials for RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA) explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA) trials appear

Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Targeted radiation delivered directly to brain tumor cavity in new trial

Disease control Recruiting now

This early-phase trial tests a single dose of a radioactive drug called [177Lu]Lu-XT771 in people with recurrent glioblastoma, an aggressive brain cancer. The drug is injected directly into the cavity left after tumor removal surgery, aiming to deliver radiation precisely to canc…

Matched conditions: RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA)

Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA)

Get alerted when new RECURRENT GLIOBLASTOMA (WHO-GRADE IV GLIOMA) trials appear

Targeted radiation delivered directly to brain tumor cavity in new trial